Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study

Prader–Willi Syndrome (PWS) is a rare genetic syndrome leading to severe behavioural disorders and mild cognitive impairment. The objective of this double-blind randomised placebo-controlled trial was to study the efficacy and tolerance of topiramate on behavioural disorders in patients with PWS. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Consoli, Angèle, Çabal Berthoumieu, Sophie, Raffin, Marie, Thuilleaux, Denise, Poitou, Christine, Coupaye, Muriel, Pinto, Graziella, Lebbah, Said, Zahr, Noel, Tauber, Maïthé, Cohen, David, Bonnot, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828670/
https://www.ncbi.nlm.nih.gov/pubmed/31685813
http://dx.doi.org/10.1038/s41398-019-0597-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828670/
https://www.ncbi.nlm.nih.gov/pubmed/31685813
http://dx.doi.org/10.1038/s41398-019-0597-0

Ejemplares similares